Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
10.1245/s10434-007-9471-z
Annals of Surgical Oncology 14:2766-2772 (2007)
© 2007 Society of Surgical Oncology
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuo, L.-J.
Right arrow Articles by Chung, Y.-L.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kuo, L.-J.
Right arrow Articles by Chung, Y.-L.

Original Article

Is Final TNM Staging A Predictor for Survival in Locally Advanced Rectal Cancer after Preoperative Chemoradiation Therapy?

Li-Jen Kuo, MD1, Mei-Ching Liu, MD2, James Jer-Min Jian, MD3, Cheng-Fang Horng, MS4, Tsun-I Cheng, MD5, Chung-Ming Chen, MD1, Wei-Tse Fang, MD2 and Yih-Lin Chung, MD3

1 Division of Colorectal Surgery, Department of Surgery, Koo Foundation Sun Yat-Sen Cancer Center Hospital, Taipei, Taiwan
2 Department of Medical Oncology, Koo Foundation Sun Yat-Sen Cancer Center Hospital, Taipei, Taiwan
3 Department of Radiation Oncology, Koo Foundation Sun Yat-Sen Cancer Center Hospital, Taipei, Taiwan
4 Department of Clinical Research, Koo Foundation Sun Yat-Sen Cancer Center Hospital, Taipei, Taiwan
5 Division of Hepatogastroenterology, Department of Internal Medicine, Koo Foundation Sun Yat-Sen Cancer Center Hospital, Taipei, Taiwan

Correspondence: Address correspondence and reprint requests to: Li-Jen Kuo, MD; E-mail: kuolijen{at}mail.kfcc.org.tw

Background: Neoadjuvant chemoradiation therapy has improved the local control rate and overall survival in locally advanced rectal cancers. The purpose of this retrospective study is to evaluate the correlation between the final pathologic stage and survival in these patients.

Methods: Patients with biopsy-proven rectal carcinoma, pretreatment staging by magnetic resonance imaging such as T3 or T4 tumors, or node-positive disease were treated with preoperative concomitant 5-fluorouracil-based chemotherapy and radiation, followed by radical surgical resection. Clinical outcome with survival, disease-free survival, recurrence rate, and local recurrence rate were compared with each T and N findings using the American Joint Committee on Cancer Tumor-Node-Metastasis (TNM) staging system.

Results: A total of 248 patients were enrolled in this study. Overall survival and disease-free survival at 1, 3, and 5 years were 97.1, 92, and 89.9% and 87.5, 71.1, and 69.5%, respectively. Thirty-six patients (14.5%) had a pathologic complete response after neoadjuvant therapy. The recurrence rate was significantly different between the pathologic complete response group and residual group (5.6 vs 31.1%; P = .002). Five-year disease-free survival was significantly better in the complete response group than the residual tumor group (93 vs 66%; P = .0045). There was no statistical difference in survival or locoregional recurrence rate between these two groups.

Conclusions: Posttreatment pathologic TNM stage is correlated to disease-free survival and tumor recurrence rate in locally advanced rectal cancer after preoperative chemoradiation. Also, pathologic complete response to neoadjuvant treatment has its oncologic benefit in both overall recurrence and disease-free survival.

Key Words: Chemoradiation • Complete response • Neoadjuvant therapy • Rectal cancer • Survival • TNM stage






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the Society of Surgical Oncology.